A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Clinical trial NCT01376297 · COMPLETED

Trial details

NCT number: NCT01376297
Sponsor: Helsinn Healthcare SA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting

Start date: 2011-07-01
Primary completion: 2012-09-01
Enrollment: 413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.